Effects of the somatomedins and insulin on myoblast differentiation in vitro.
D002454:Cell Differentiation / Q000187:drug effects; D003402:Creatine Kinase / Q000378:metabolism; D003907:Dexamethasone / Q000494:pharmacology; D006133:Growth Substances / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology*; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D009132:Muscles / Q000166:cytology* / Q000187:drug effects; D010455:Peptides / Q000494:pharmacology; D013002:Somatomedins / Q000494:pharmacology*; D000509:alpha-Fetoproteins / Q000494:pharmacology
D006133:Growth Substances; D007328:Insulin; D010455:Peptides; D013002:Somatomedins; D000509:alpha-Fetoproteins; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D003907:Dexamethasone; D003402:Creatine Kinase